Navigation Links
PAREXEL Appoints Leading Central Nervous System Experts to Its Global Clinical Pharmacology Business
Date:4/2/2008

"Risk Factors" of the Company's Quarterly Report on Form 10-Q for the period ended December 31, 2007 as filed with the SEC on February 7, 2008, which "Risk Factors" discussion is incorporated by reference in this press release. The forward-looking statements included in this press release represent the Company's estimates as of the date of this release. The Company specifically disclaims any obligation to update these forward-looking statements in the future. These forward-looking statements should not be relied upon as representing the Company's estimates or views as of any date subsequent to the date of this press release.

PAREXEL is a registered trademark of PAREXEL International Corporation, and PERCEPTIVE INFORMATICS is a registered trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.

Contacts:

Jennifer Baird, Director of Public Relations Rebecca Passo

PAREXEL International SHIFT Communications

Tel: +781-434-4409 Tel: +617-681-1817

Email: Jennifer.Baird@PAREXEL.com Email: rpasso@shiftcomm.com


'/>"/>
SOURCE PAREXEL International Corporation
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. PAREXEL International Expands Relationship with Synchron Research in India and Divests Bioanalytical Laboratory in France
2. PAREXEL Announces Date of Third Quarter Fiscal Year 2008 Earnings Release and Conference Call
3. PAREXEL Appoints Leading Biopharmaceutical Marketing Expert Jacque Fisher to Medical Communications Services Executive Team
4. PAREXEL International to Present at Lehman Brothers 11th Annual Global Healthcare Conference
5. PAREXEL International to Present at Raymond James 29th Annual Institutional Investors Conference
6. PAREXEL to Present Leading Insights Regarding Key Industry Topics at 20th Annual Drug Information Association EuroMeeting
7. PAREXEL International Announces 2-For-1 Stock Split
8. PAREXEL Reports Second Quarter Fiscal Year 2008 Financial Results
9. PAREXEL Names Biopharmaceutical Industry Executive Eduard E. Holdener to Board of Directors
10. PAREXEL Announces Date of Second Quarter Fiscal Year 2008 Earnings Release and Conference Call
11. PAREXEL Appoints Charles A. Stevens as Vice President/General Manager of Health Policy and Strategic Reimbursement and Strengthens Capabilities

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)...Pa. and WALTHAM, Mass., Nov. 19 Ar...rces find that the leading driver of antibiotic se...-spectrum activity against gram-positive and gram-...s that can cause nosocomial pneumonia, surveyed Eu...for agents that provide appropriate coverage again...
(Date:11/19/2009).... 19 /PRNewswire/ - Aegera Therapeutics Inc. annou...ndomized Phase 2B study of AEG35156, a targeted an...ultiple oncology indications. ,, The study, ent...he X-Linked Inhibitor of Apoptosis (XIAP) Antisens...arabine and Idarubicin in AML Following Failure of...
(Date:11/19/2009)... World,s Top Gene Synthesis Companies Form Intern...nate Best Practices in Risk Reduction ,Five Memb...e Synthesis Capacity , (P...;s leading gene synthesis companies today announce...g protocol to promote biosecurity in the gene synt...
(Date:11/19/2009)...A, Austria, November 19 AFFiRiS AG... product candidate at an unexpectedly early,stage ...ned to enter into,Phase II clinical trial early in...llows the completion of two Phase I trials with th...fast decision on the first interim,analysis of the...
Breaking Biology Technology:Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Aegera Therapeutics Initiates a Randomized Phase 2B Study with AEG35156 for the Treatment of Acute Myeloid Leukemia (AML) 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 2World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 3World's Top Gene Synthesis Companies Establish Tough Biosecurity Screening Protocol 4AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 2AFFiRiS AG: Interim Analysis of Clinical Phase I Data Triggered Decision to Move Alzheimer's Vaccine Candidate AD02 into Clinical Phase II Testing 3
...pril 22 ACCESS PHARMACEUTICALS, INC. (OTC Bulle...), its proprietary polymer-based oral mucositis pr...ece and the Nordic countries by its European comme...pharmaceutical company dedicated to the provision ...critical care. , , Under a license from Access P...
...Can Influence New Product Development and Innovati...t end-user study from Frost & Sullivan,s Pharm...riety of critical dynamics of drug delivery approa...ians, nurses and patients provided insight on fact...e vs. office administration parameters, and barrie...
...HAI, April 22 /PRNewswire-Asia-FirstCall/ -- China... "the Company"), a leading Chinese firm,specializi...eting and,distribution of probiotics products, tod...nong Group ("Dabeinong") to supply probiotics as b...er the initial purchase order, which has already b...
Other Biology Technology:Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 2Access Pharmaceuticals Announces the European Launch of MuGard(TM) by its European Partner, SpePharm 3Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 2Frost & Sullivan: Female Cancer Patients More Willing to Use Implantable Infusion Pumps Than Males 3China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 2China-Biotics, Inc. Supplies Probiotics as Additive for Poultry Feed 3
(Date:11/23/2009)...lied mathematicians dissected the morphology of th...stic long leaf with a saddle-like arc midsection a...ple cause of the lily,s fan-like shapeelastic rela...growthwas revealed by using an equally simple tech... postdoctoral student at Harvard,s School of Engin...
(Date:11/23/2009)...ay matters to forest trees dealing with drought, a...m led by Professor Malcolm Campbell, University of... and colleagues in the department of cell and syst...lizing on their previous work to decode the genome...w poplar trees use their 45,000 genes to respond t...
(Date:11/23/2009)...ociety says that western lowland gorillas living i...e "mother lode" of more than 125,000 gorillas disc...ed by growing humans activity in the region. , T...s adjacent to the southwest border of Lac Tl Commu...igh densities of the great apes still exist in the...
Breaking Biology News(10 mins):The cause behind the characteristic shape of a long leaf revealed 2Time of day matters to thirsty trees, U of T researcher discovers 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 1Blood Test Shows Statistically Significant Association With Alzheimers Disease 28AD 29 May Predict Conversion of Mild Cognitive Impairment to AD 51872 2Sinovac Adjourns 2008 Annual General Meeting 13056 1Sinovac Adjourns 2008 Annual General Meeting 13056 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 1AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 2AstraZeneca and Mental Health Research Institute in Australia Announce Collaboration to Improve Early Detection of Alzheimers Disease 51870 3
...or it, a survival guide for bacteria might include...st from going apoptotic." A host,s cells can respo...grammed cell death. For bacteria that pass directl...he bacteria are highly virulent and induce too muc...re they,re able to jump ship, thus hurting the bac...
... professor who last year won a Presidential Award,...g the promise of stem cell research one step close...of biomedical engineering at NJIT, is researching ...esearch will help diabetics whose impaired bones w...ls, in combination with allografts ?donated bone t...
...ersity of Illinois at Chicago have identified a me... based on the sensitivity of cellular DNA to enzym...al., "Chromatin sensitivity to Alu I restriction e...y the extracellular matrix and cytoskeleton," appe...l of Pathology and is accompanied by a commentary....
Other Biology News:The Bacteria's guide to survival 2NJIT Presidential Award winner takes stem cell research another step 2NJIT Presidential Award winner takes stem cell research another step 3Study of genomic DNA leads to new advances in cancer diagnostics 2
.../antibody delivery using PULSin may be superior to...unlike traditional transfection, with PULSin you c... time course of proteins in cells. Likewise, deliv...ation than traditional RNA interference experiment...
...XY is an automated instrument with a thin silicon ... light or fluorescence microscopy. Biaxial strain ...broblast cells can be simulated by mechanical stre...r strain chamber. Strain can be applied simultaneo...
Mechanical Cell Strain Instrument ST-160 Microscope Mountable from B-Bridge International
...lation is a post-translational modification that p...cluding immune regulation, inflammation, cell-to-c...logy has developed two lectin based Glycoprotein I...m Agglutinin (WGA), that allow isolation of glycop...
Biology Products: